Drugs / Mistletoe extract
Mistletoe extract
also known as
Abnoba Viscum · abnobaVISCUM 900 · abnobaVISCUM Fraxini · European Mistletoe · Helixor M · mistletoe
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT03051477 | Mar 2017 → Jan 2021 | neoplasm | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
| Phase 1 | NCT00049608 | Jul 2002 → Aug 2011 | breast cancer, colorectal cancer, lung cancer, malignant pancreatic neoplasm | National Center for Complementary and Integrative Health (NCCIH) | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02007005 | Jan 2004 → Feb 2012 | superficial urinary bladder carcinoma | Abnoba GmbH | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00516022 | Apr 2007 → Mar 2011 | non-small cell lung carcinoma | Rambam Health Care Campus | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02106572 | Apr 2015 → Mar 2026 | superficial urinary bladder carcinoma | Abnoba GmbH | Terminated | No outcome recorded |
| Phase 3 | NCT02191540 | Jan 2011 → Jan 2013 | pleural neoplasm | Abnoba Korea | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mistletoe extract | “mistletoe extract” NCT00049608 ↗ |
| Known as | Abnoba Viscum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02191540 ↗ |
| Known as | abnobaVISCUM 900 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02106572 ↗ |
| Known as | abnobaVISCUM Fraxini | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02007005 ↗ |
| Known as | European Mistletoe | “European Mistletoe (Viscum album L.) extracts (mistletoe) are commonly used for cancer treatment in Europe.” PMID 24285980 ↗ Oct 2013 |
| Known as | Helixor M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03051477 ↗ |
| Known as | mistletoe | “European Mistletoe (Viscum album L.) extracts (mistletoe) are commonly used for cancer treatment in Europe.” PMID 24285980 ↗ Oct 2013 |
| Route | Subcutaneous | “mistletoe subcutaneously daily starting on day 8 of course 1” NCT00049608 ↗ |